Result of AGM

RNS Number : 4492N

IXICO plc

29 January 2016

 

29 January 2016

Results of AGM

IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

Enquiries:

IXICO plc	[phone]
Derek Hill, CEO
Susan Lowther, CFO
Peel Hunt LLP (Nominated Adviser and Broker)	[phone]
James Steel / Oliver Jackson
Daniel Stewart & Company (Joint Broker)	[phone]
Martin Lampshire / David Coffman
FTI Consulting Limited (Investor Relations)	[phone]
Simon Conway / Mo Noonan / Matthew Moss

Notes to Editors

About IXICO

IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions.  In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes.  In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, behavioural health, child and adolescent mental health.

More information is available on www.ixico.com.

 

END

 

 

RAGAKCDQKBKDDDB